O. Vagner

1.3k total citations
18 papers, 926 citations indexed

About

O. Vagner is a scholar working on Infectious Diseases, Epidemiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, O. Vagner has authored 18 papers receiving a total of 926 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 8 papers in Epidemiology and 5 papers in Health, Toxicology and Mutagenesis. Recurrent topics in O. Vagner's work include Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (6 papers) and Indoor Air Quality and Microbial Exposure (5 papers). O. Vagner is often cited by papers focused on Antifungal resistance and susceptibility (13 papers), Fungal Infections and Studies (6 papers) and Indoor Air Quality and Microbial Exposure (5 papers). O. Vagner collaborates with scholars based in France, Czechia and Myanmar. O. Vagner's co-authors include Denis Caillot, Gérard Couillault, Alain Bonnin, Henri Guy, Frédéric Dalle, Alain Bernard, David W. Denning, F Piard, Lionel Mannone and Olivier Casasnovas and has published in prestigious journals such as Journal of Clinical Oncology, The Science of The Total Environment and Applied and Environmental Microbiology.

In The Last Decade

O. Vagner

18 papers receiving 892 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
O. Vagner France 13 649 556 158 116 106 18 926
B. Cuisenier France 12 766 1.2× 721 1.3× 153 1.0× 88 0.8× 140 1.3× 21 1.1k
J. Waller France 13 654 1.0× 576 1.0× 16 0.1× 176 1.5× 41 0.4× 24 798
Tiyomi Akiti Brazil 16 445 0.7× 406 0.7× 26 0.2× 291 2.5× 53 0.5× 23 820
Greetje A. Kampinga Netherlands 20 1.2k 1.8× 985 1.8× 21 0.1× 269 2.3× 111 1.0× 43 1.7k
Zekaver Odabaşı Türkiye 14 1.1k 1.6× 714 1.3× 12 0.1× 120 1.0× 80 0.8× 33 1.3k
M. A. Piens France 15 572 0.9× 453 0.8× 20 0.1× 90 0.8× 31 0.3× 29 775
Rosemary A. Barnes United Kingdom 10 689 1.1× 629 1.1× 12 0.1× 235 2.0× 50 0.5× 17 806
Claudine Pinel France 15 592 0.9× 458 0.8× 15 0.1× 96 0.8× 162 1.5× 39 803
Antonius J. M. M. Rijs Netherlands 23 1.5k 2.3× 1.1k 1.9× 18 0.1× 460 4.0× 103 1.0× 32 1.8k
Sebastian van Hal Australia 13 495 0.8× 182 0.3× 10 0.1× 66 0.6× 39 0.4× 18 878

Countries citing papers authored by O. Vagner

Since Specialization
Citations

This map shows the geographic impact of O. Vagner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Vagner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Vagner more than expected).

Fields of papers citing papers by O. Vagner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Vagner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Vagner. The network helps show where O. Vagner may publish in the future.

Co-authorship network of co-authors of O. Vagner

This figure shows the co-authorship network connecting the top 25 collaborators of O. Vagner. A scholar is included among the top collaborators of O. Vagner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Vagner. O. Vagner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Sendid, Boualem, Patrick Ducoroy, Nadine François, et al.. (2012). Evaluation of MALDI-TOF mass spectrometry for the identification of medically-important yeasts in the clinical laboratories of Dijon and Lille hospitals. Medical Mycology. 51(1). 25–32. 60 indexed citations
2.
3.
Sautour, Marc, Frédéric Dalle, Coralie L’Ollivier, et al.. (2011). Dynamics of fungal colonization in a new medical mycology laboratory. Journal de Mycologie Médicale. 22(1). 14–20. 5 indexed citations
4.
Sautour, Marc, Nathalie Sixt, Frédéric Dalle, et al.. (2009). Profiles and seasonal distribution of airborne fungi in indoor and outdoor environments at a French hospital. The Science of The Total Environment. 407(12). 3766–3771. 113 indexed citations
5.
Dalle, Frédéric, Ingrid Lafon, Coralie L’Ollivier, et al.. (2008). A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia. Haematologica. 93(4). 581–587. 19 indexed citations
6.
Sautour, Marc, Frédéric Dalle, O. Vagner, et al.. (2008). A prospective survey of air and surface fungal contamination in a medical mycology laboratory at a tertiary care university hospital. American Journal of Infection Control. 37(3). 189–194. 12 indexed citations
7.
Gaschet, Anne, Coralie L’Ollivier, A. Laplanche, et al.. (2008). Evaluation of CandiSelect4, a new chromogenic medium for isolation and presumptive identification of Candida species from clinical specimens. Journal de Mycologie Médicale. 18(2). 89–95. 4 indexed citations
8.
Sautour, Marc, Nathalie Sixt, Frédéric Dalle, et al.. (2007). Prospective survey of indoor fungal contamination in hospital during a period of building construction. Journal of Hospital Infection. 67(4). 367–373. 53 indexed citations
9.
Sixt, Nathalie, Frédéric Dalle, Ingrid Lafon, et al.. (2006). Reduced fungal contamination of the indoor environment with the Plasmair™ system (Airinspace). Journal of Hospital Infection. 65(2). 156–162. 27 indexed citations
10.
Dalle, Frédéric, Laure Dumont, Denis Caillot, et al.. (2003). Genotyping of Candida albicans Oral Strains from Healthy Individuals by Polymorphic Microsatellite Locus Analysis. Journal of Clinical Microbiology. 41(5). 2203–2205. 30 indexed citations
11.
Aho, Serge, Denis Caillot, O. Vagner, et al.. (2001). Decrease in Candida albicans strains with reduced susceptibility to fluconazole following changes in prescribing policies. Journal of Hospital Infection. 48(2). 122–128. 22 indexed citations
12.
Caillot, Denis, Alain Bernard, Olivier Casasnovas, et al.. (2001). Increasing Volume and Changing Characteristics of Invasive Pulmonary Aspergillosis on Sequential Thoracic Computed Tomography Scans in Patients With Neutropenia. Journal of Clinical Oncology. 19(1). 253–259. 431 indexed citations
13.
Dalle, Frédéric, et al.. (2001). Rapid Identification of Candida glabrata Based on Trehalose and Sucrose Assimilation Using Rosco Diagnostic Tablets. Journal of Clinical Microbiology. 39(3). 1172–1174. 15 indexed citations
14.
Dalle, Frédéric, O. Vagner, Denis Caillot, et al.. (2000). Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus. Journal of Clinical Microbiology. 38(12). 4554–4559. 49 indexed citations
15.
López, José I., Denis Caillot, O. Vagner, et al.. (1998). Diagnosis of disseminated toxoplasmosis by PCR analysis of ascitic fluid in a patient with haematologic malignancy. Clinical Microbiology and Infection. 4(4). 223–224. 2 indexed citations
16.
Naciri, Muriel, et al.. (1998). Failure To Differentiate Cryptosporidium parvum from C. meleagridis Based on PCR Amplification of Eight DNA Sequences. Applied and Environmental Microbiology. 64(4). 1454–1458. 22 indexed citations
17.
Vagner, O., Michèle Grappin, Dominique Aubert, et al.. (1997). Detection of Cryptosporidium parvum DNA in formed human feces by a sensitive PCR-based assay including uracil-N-glycosylase inactivation. Journal of Clinical Microbiology. 35(1). 254–256. 22 indexed citations
18.
Vagner, O., Serge Aho, Denis Caillot, et al.. (1995). Sensibilité au fluconazole de 164 souches de Candida spp. isolées d'hémocultures ou de prélèvements oropharyngés chez des patients recevant ou non une chimioprophylaxie par fluconazole. Médecine et Maladies Infectieuses. 25(8-9). 919–926. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Cuisenier Breakdown of academic impact, for papers by J. Waller Breakdown of academic impact, for papers by Tiyomi Akiti Breakdown of academic impact, for papers by Greetje A. Kampinga Breakdown of academic impact, for papers by Zekaver Odabaşı Breakdown of academic impact, for papers by M. A. Piens Breakdown of academic impact, for papers by Rosemary A. Barnes Breakdown of academic impact, for papers by Claudine Pinel Breakdown of academic impact, for papers by Antonius J. M. M. Rijs Breakdown of academic impact, for papers by Sebastian van Hal
Rankless by CCL
2026